WNDM Stock UPDATES Wound Mgmt Tech (WNDM) 0.0909 08/20/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Wound Mgmt Tech (WNDM) 0.0909 $WNDM

Wound Management Technologies Launches Risk-Sharing Program to Reimburse Hospitals for Certain SSI Costs to Highlight Effectiveness of CellerateRX(r) Surgical
ACCESSWIRE - Tue Aug 19, 7:31AM CDT
Addison, TEXAS / ACCESSWIRE / August 19, 2014 / Wound Management Technologies, Inc. (OTC QB: WNDM), an emerging commercial stage company with its primary product, a patented-protected and FDA-cleared collagen product, CellerateRX(r), today announced that its Wound Care Innovations subsidiary has launched the CellerateRX(r) Surgical Assurance Program, a risk-sharing program to help hospitals and surgical centers lower the uncompensated care costs associated with readmissions due to surgical site infections (SSIs).

Wound Management Technologies Reports Financial Results for the Second Quarter Ended June 30, 2014
ACCESSWIRE - Thu Aug 14, 3:06PM CDT
Addison, TX / ACCESSWIRE / August 14, 2014 / Wound Management Technologies, Inc. (OTCQB: WNDM), an emerging commercial stage company with its primary product, a patented-protected and FDA-cleared collagen product, CellerateRX(r), today announced its financial and operating results for the three month period ended on June 30, 2014.

Wound Management Technologies, Inc. Retains KCSA Strategic Communications as U.S. Investor Relations Counsel
ACCESSWIRE - Thu Jul 31, 10:52AM CDT
Addison, TEXAS / ACCESSWIRE / July 31, 2014 / Wound Management Technologies, Inc. (OTC BB: WNDM), an emerging commercial stage company with its primary product, a patented-protected and FDA- approved collagen product, CellerateRX(R), today announced that it has retained KCSA Strategic Communications, a leading New York-based communications firm, to lead the Company's investor relations program.

Markets for Advanced Wound Management Technologies
PR Newswire - Thu Jun 19, 6:51AM CDT
Reportlinker.com announces that a new market research report is available in its catalogue:

Global Market for Advanced Wound Management to Reach $11.3 Billion in 2018; Wound Healing Devices Moving at 7.6%
PRWeb - Tue Jun 10, 9:50AM CDT
BCC Research (http://www.bccresearch.com) reveals in its new report, MARKETS FOR ADVANCED WOUND MANAGEMENT TECHNOLOGIES, the global market for advanced wound management is expected to grow to $11.3 billion by 2018, with a five-year compound annual growth rate (CAGR) of 5.6%. Growth in this market is significantly influenced by the aging and growing global population, as well as new technologies and increasing incidence of difficult-to-heal wounds.

Wound Management Technologies Announces Jane Fore, MD as Chief Medical Officer and Dr. Alec Hochstein as Medical Director
ACCESSWIRE - Wed Mar 19, 8:41AM CDT
ADDISON, TX / ACCESSWIRE / March 19, 2014 / Wound Management Technologies, Inc., (OTCQB: WNDM), announced today that Dr. Jane Fore is the new Chief Medical Officer for the Wound Care Innovations Subsidiary and Dr. Alec Hochstein has joined the company as Medical Director. Both are actively involved in the CellerateRX(R) Activated Collagen product line.

Wound Management Technologies Adds CFO and Director of Research and Development
ACCESSWIRE - Mon Mar 17, 3:11PM CDT
ADDISON, TX / ACCESSWIRE / March 17, 2014 / Wound Management Technologies, Inc., (OTCQB: WNDM) has engaged Mr. Darren Stine as the Company's new Chief Financial Officer and Mr. Barry Constantine has agreed to expand his role within the Company as its new Director of Research and Development.

Wound Managements' Subsidiary, Resorbable Orthopedic Products, Announces BioStructures has FDA 510(k) Clearance for Innovative Bioactive Bone Graft Putty and Bone Graft Extender; Commercial License Granted
ACCESSWIRE - Tue Feb 18, 7:36AM CST
ADDISON, TX - (ACCESSWIRE - February 18, 2014) - Wound Management Technologies, Inc., (OTCQB: WNDM) announced today that its subsidiary, Resorbable Orthopedic Products, LLC, has granted a commercial license to BioStructures, LLC to market their newly FDA 510(k) cleared Bioactive Bone Graft Putty (Signafuse™). BioStructures developed this product under the Development and License Agreement with ROP that was announced on November 11, 2011 under which BioStructures combined their proprietary biomaterials with ROP's patented resorbable wax carrier. This license creates Resorbable Orthopedic Products first revenue stream.

Wound Management Technologies Inc. Receives Financing from Key Shareholder Group; Turns Focus to Strategic Growth
ACCESSWIRE - Wed Dec 18, 8:17AM CST
ADDISON, TX - (Accesswire - December 18, 2013) - Wound Management Technologies, Inc., (OTCQB: WNDM) announced today that it has received a financing commitment from existing shareholders to invest an additional $2.4 million in Series C preferred shares and to convert over $1.5 M of existing debt to the Series C preferred shares. The financing subscription documents have been received and the commitment will be fully funded by February 28, 2014. The Board of Directors unanimously supported this action and authorized a $3 M extension to the Series C offering.

Wound Management Technologies and Brookhaven Medical Agree to Explore Business Relationships, not a Merger
ACCESSWIRE - Fri Dec 13, 1:14PM CST
Addison, TX - (ACCESSWIRE- December 13, 2013) Wound Management Technologies Inc. (OTCQB:WNDM) and Brookhaven Medical, Inc. announced today that they have mutually agreed not to proceed with a previously announced merger. Both companies and their boards have determined it to be in the best interests of their companies and stockholders respectively not to enter into a definitive merger agreement.

CellerateRX(R) Reports Significant Second Quarter and Annual Sales Increase
Marketwire - Mon Aug 26, 8:47AM CDT
Wound Management Technologies, Inc. (OTCQB: WNDM) announces an increase in sales of CellerateRX(R) for the second quarter, ending June 2013 up 54% over the same period in 2012. Sales year to date have risen 111% over year to date sales in 2012. Robert Lutz Jr., chief executive officer, commented, "We attribute our growing success to increased use of CellerateRx for surgical wounds in hospitals and increased use in the woundcare marketplace." Lutz added, "We will continue to expand our sales and distribution efforts with hospitals, woundcare centers, and the longterm care and hospice market places adding new accounts based on the strong efficacy of the product."

Wound Management Technologies Enters Into Distribution Agreement With Academy Medical
Marketwire - Mon Jul 08, 3:30PM CDT
Wound Management Technologies, Inc. (OTCQB: WNDM) announced it has entered into a distribution agreement with Academy Medical, LLC, a veteran-owned distributor of medical products, to sell its CellerateRX line of products to the VA facilities across the country. The Veterans Administration system represents over 168 Hospitals, 1700 "sites of care" facilities and 8.3 million veterans. The agreement has a term of five years and minimum purchase amounts from Wound Management of $600,000 and 1.5 million the first two years growing to $3 million by year five of the contract.

Wound Management Technologies 2012 Sales Strategy Shows Positive Results; Receives Final Resolution with SEC
PR Newswire - Tue Feb 05, 9:30AM CST
WOUND MANAGEMENT TECHNOLOGIES (OTCQB: WNDM | WNDM.PK) finished 2012 with fourth quarter customer sales revenues of approximately $440,000 (an increase of 23% over the previous quarter) and annual sales revenues of approximately $1.18M. In May of 2012 the Company announced it had completed a new three-year strategic plan that focuses on CellerateRX® customer sales and that a new surgical product would be introduced in 2012. In October 2012 the Company announced positive results for the new CellerateRX® surgical products. "Clearly our plan and our team's efforts are yielding results," stated Robert H. Lutz, Jr., Chairman and CEO of the company. "We expect the upward sales trend to continue throughout 2013 and beyond."




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fuel Cell Market Faces Uneven Growth Amid Revenue Shifts

Updated Category News Views 120

Fuel Cell Sector Eyes Mixed Results and Big Projections The fuel cell market, oh what a beast it's becoming—a story filled with ups and downs, and more forecasts than a weather station. As we stand, this sector is poised to balloon to an $18.16 billion market by 2030. That's a growth rate of 26.3% annually, folks. These projections are driving excitement, but the...

Continue Reading
Kos & FORTH Partner to Spark Greek Biotech Growth

Updated Category News Views 65

New Frontiers: Greece on the Biotech Map Partnerships in biotech aren't tossed out willy-nilly; they're crafted for precision much like a sculptor shaping marble. Kos Biotechnology Partners and the Foundation for Research and Technology-Hellas (FORTH) are doing exactly that, teaming up to birth a biotechnology incubator on the FORTH campus in Heraklion, Crete. Now tell...

Continue Reading
Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 46

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
Austin Rattler Event Revamps With Two-Day Off-Road Bash

Updated Category News Views 42

Austin's Off-Road Bash Kicks Up Dust in Hill Country It's not just another grind in the biking and running world; the Life Time Austin Rattler's gone off the reservation pushing the pedals and the pace across the rugged terrain of Texas Hill Country. Here's to muscles burning and soles slapping the dirt for two straight days, all in the name of challenging nature's best....

Continue Reading
Biotech Hit or Miss: Trials and Tribulations

Updated Category News Views 96

Biotech's Roller Coaster: Triumphs and Setbacks Ah, the biotech sector—it's a bit like jumping on a bull, ain't it? You barely hang on when the beast bucks. Monday's market action was downright wild. The S&P 500 didn't have a party, tumbling 1.92%, and the Nasdaq wasn't any friendlier, plummeting 2.49%. Yet, inside this storm, we see some biotech names either catching...

Continue Reading
Sandals Foundation: Win a Trip, Boost Caribbean Education

Updated Category News Views 100

Sandals Resorts Stakes a Claim in Education While the rest of us are gravitating towards Black Friday deals and Cyber Monday sales, the Sandals Foundation decided to play a different game. This Giving Tuesday, they invite travelers not just to soak in the sun, but to spread a little of it around by supporting education for kids across the Caribbean. It's a classic example...

Continue Reading
Xiong'an New Area: People's Priorities Reshape Living Spaces

Updated Category News Views 143

Building a City for the People This here is about prioritizing people over skylines. Xiong'an New Area in Hebei Province is shaping up to be more than just a place on the map; it's an experiment in redefining urban living. Skyscrapers and traffic jams? Not on this menu. Instead, nature paves a graceful dance floor between mid-rise residences. Forget your bustling city...

Continue Reading
Radiate Holdco's Q3 Results: What We Know Now

Updated Category News Views 69

Digging Into Third Quarter Highlights Radiate Holdco, LLC has just thrown its third-quarter financial hat into the ring, stirring up some interest in the world of FLFO secured notes and senior notes. The folks in Princeton, N.J., sure know how to keep things exclusive—this intel is only for those holding their Notes or in the pretty exclusive club of qualified...

Continue Reading
BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 139

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading
BWIN Acquisition Under Scrutiny: Shareholders Alerted

Updated Category News Views 75

BWIN Shareholders in the Hot Seat Over Acquisition Ever feel like you're the last one to know when the music stops in this investing dance? Well, if you're holding shares of The Baldwin Insurance Group, Inc. (NASDAQ:BWIN), it's time to put down your coffee and tune in. Levi & Korsinsky, LLP threw a wrench in the works, launching an investigation to see if this Sequence...

Continue Reading

Top 5 Most Recently Viewed Articles

Twist Bioscience Set to Showcase Innovations at J.P. Morgan Event

Updated Category News Views 105

Twist Bioscience to Present at Renowned Healthcare Conference Twist Bioscience Corporation (NASDAQ: TWST), a prominent player in the synthetic biology and genomics field, has announced an upcoming presentation at the annual J.P. Morgan Healthcare Conference. This significant event is slated for January, and it serves as a vital platform for the company to showcase its...

Continue Reading
Leidos Secures Major NSA Contract Worth $390 Million

Updated Category News Views 154

Leidos Wins $390 Million NSA Signals Intelligence Contract Leidos, a prominent player in the defense and technology sectors, has recently secured a significant contract to enhance the capabilities of the National Security Agency (NSA) in the field of signals intelligence (SIGINT). This contract, valued at $390 million, will span an initial year with four additional...

Continue Reading
Devin Shanahan's Strategic Innovations in Global Trade Adaptation

Updated Category News Views 165

Adapting to Global Trade Challenges In a rapidly changing trade landscape, Devin Shanahan, co-founder of the innovative consumer brand Funtazma, is leading thoughtful changes in supply chain management due to the growing impact of U.S.-China trade tensions. With a wealth of experience in scaling consumer brands through global sourcing, Shanahan has been pivotal in guiding...

Continue Reading
Animal Nutrition Chemicals Market Insights and Growth Prospects

Updated Category News Views 185

Animal Nutrition Chemicals Market Overview The rapidly evolving animal nutrition chemicals market is poised for remarkable growth. As the need for high-quality and nutritious animal feed continues to escalate, this sector is likely to see significant changes and expansion. Comprehensive analyses reveal a bright future as industry players adapt to shifting demands and...

Continue Reading
Investors Ensnared in Orthofix Securities Fraud Case Seek Justice

Updated Category News Views 49

Understanding the Orthofix Securities Fraud Case Recently, investors in Orthofix Medical Inc. were informed about a serious legal action involving alleged securities fraud. The Schall Law Firm, which advocates for shareholder rights, is leading a class action lawsuit that addresses the alleged missteps by Orthofix during a specific time frame. It’s important for...

Continue Reading